|
Neoplasia
Citations 141-150 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia
- Lisa Kujawski, Peter Ouillette, Harry Erba, Chris Saddler, Andrzej Jakubowiak, Mark Kaminski, Kerby Shedden, and Sami N. Malek
Blood 2008; 112: 1993-2003.
[Abstract]
[Full text]
[PDF]
Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor
- Magali Colombat, Hervé Mal, Christiane Copie-Bergman, Jacques Diebold, Diane Damotte, Patrice Callard, Michel Fournier, Jean-Pierre Farcet, Marc Stern, and Marie-Hélène Delfau-Larue
Blood 2008; 112: 2004-2012.
[Abstract]
[Full text]
[PDF]
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
- Susan P. Whitman, Björn Hackanson, Sandya Liyanarachchi, Shujun Liu, Laura J. Rush, Kati Maharry, Dean Margeson, Ramana Davuluri, Jing Wen, Tatiana Witte, Li Yu, Chunhui Liu, Clara D. Bloomfield, Guido Marcucci, Christoph Plass, and Michael A. Caligiuri
Blood 2008; 112: 2013-2016.
[Abstract]
[Full text]
[PDF]
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl
- Christopher Slape, Leah Y. Liu, Sarah Beachy, and Peter D. Aplan
Blood 2008; 112: 2017-2019.
[Abstract]
[Full text]
[PDF]
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
- David T. Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I. Brown, Jonathan Fish, Gregor S. D. Reid, Alix E. Seif, Robin Norris, Yueh J. Chang, Martin Carroll, and Stephan A. Grupp
Blood 2008; 112: 2020-2023.
[Abstract]
[Full text]
[PDF]
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
- Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, and François-Xavier Mahon
Blood 2008; 112: 2024-2027.
[Abstract]
[Full text]
[PDF]
Mast cells and mastocytosis
- Dean D. Metcalfe
Blood 2008; 112: 946-956.
[Abstract]
[Full text]
[PDF]
Whole genome scanning as a cytogenetic tool in hematologic malignancies
- Jaroslaw P. Maciejewski and Ghulam J. Mufti
Blood 2008; 112: 965-974.
[Abstract]
[Full text]
[PDF]
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- Constantine S. Tam, Susan O'Brien, William Wierda, Hagop Kantarjian, Sijin Wen, Kim-Anh Do, Deborah A. Thomas, Jorge Cortes, Susan Lerner, and Michael J. Keating
Blood 2008; 112: 975-980.
[Abstract]
[Full text]
[PDF]
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- Guillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, Zeev Estrov, Hagop Kantarjian, Hui Yang, Willie M. Newsome, Wilson H. Miller, Jr, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, Tracy-Ann Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory Reid, Eric Laille, Robert E. Martell, and Mark Minden
Blood 2008; 112: 981-989.
[Abstract]
[Full text]
[PDF]
|
|
